Shinsei Capital Partners is a leading investment firm that specializes in supporting unlisted companies in the life sciences sector, including pharmaceutical and digital health companies. Our mission is to bridge the gap between groundbreaking research in the field and its practical implementation by providing financial support. With a deep understanding of both finance and pharmaceutical development, we leverage our knowledge and experience to contribute to technological innovation in healthcare.

Our team is dedicated to making a difference in the lives of patients, researchers, doctors, and pharmaceutical professionals by delivering innovative medical solutions. We operate New Life Science Fund 1, which was established in February 2019 with a total fund size of 10. 1 billion yen.

Our investment focus includes company creation, seed investment, early-stage, mid-stage, and late-stage investments in drug discovery ventures. With a strong leadership team and a proven track record since our inception, Shinsei Capital Partners is a trusted partner in the life sciences industry